← Back to Search

0.01% atropine for Near-sightedness

Phase < 1
Waitlist Available
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up we will record comfort of the drop for a maximum of 25 seconds
Awards & highlights

Study Summary

This trial looks at how comfortable it is to give low concentration atropine eye drops.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~we will record comfort of the drop for a maximum of 25 seconds
This trial's timeline: 3 weeks for screening, Varies for treatment, and we will record comfort of the drop for a maximum of 25 seconds for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to Return to Baseline Comfort
Secondary outcome measures
Average Comfort Score
Correlation Between Peak Comfort Score and Corneal Sensitivity
Correlation Between Peak Comfort Score and Iris Color
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment2 Interventions
All participants will receive all four drops in randomized order
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
0.01% atropine
2022
Completed Early Phase 1
~30
0.05% atropine
2022
Completed Early Phase 1
~30

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
821 Previous Clinical Trials
501,105 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still slots available for participants in this clinical examination?

"Affirmative, the details posted on clinicaltrials.gov reveal that this medical trial is currently inviting participants. The experiment was first publicized on May 19th 2022 and has since been updated as recently as May 20th 2022. This study requires 30 individuals to be enrolled from 1 location."

Answered by AI

What is the participant count for this clinical trial?

"Affirmative, clinicaltrials.gov states that this medical investigation is enrolling participants as of May 19th 2022 and was last updated on the 20th of May. 30 individuals must be enrolled at 1 site for the trial to continue."

Answered by AI
~11 spots leftby Mar 2025